Clinical, Radiological, and Etiological Aspects of Pachymeningitis: A Study of 24 Cases

Yousfi Samah1, Boulehoual Sahar1, Yassine Mebrouk1

  • 1Department of Neurology, Mohamed VI University Hospital, Mohamed First University, Faculty of Medicine, Oujda, MAR.

Cureus
|July 10, 2024
PubMed

Insights

Hypertrophic pachymeningitis (HP) is a rare condition. Prompt diagnosis via MRI and cerebrospinal fluid analysis is crucial for identifying causes like tuberculosis and improving patient prognosis.

Area of Science:

  • Neurology
  • Radiology
  • Pathology

Background:

  • Hypertrophic pachymeningitis (HP) is an uncommon disorder with diverse causes and varied symptoms.
  • Early diagnosis and etiological identification are critical for effective treatment and potential symptom reversal.

Purpose of the Study:

  • To analyze the diagnostic utility of MRI and cerebrospinal fluid studies in identifying the causes of hypertrophic pachymeningitis.
  • To evaluate the etiological spectrum and clinical presentation of HP in a cohort of patients.

Main Methods:

  • Retrospective study of 24 patients with confirmed hypertrophic pachymeningitis based on brain imaging.
  • Utilized MRI with Gadolinium contrast, cerebrospinal fluid analysis, and histopathological examination (stereotactic biopsy in one case).

Main Results:

  • MRI revealed localized (13 cases) or diffuse meningeal thickening.
  • Cerebrospinal fluid analysis showed lymphocytic predominance and hyperproteinorrhea in 50% of patients.
  • Tuberculosis was the most common etiological cause (33.3%), followed by idiopathic origin (16.7%).

Conclusions:

  • Meningeal thickening is rare, and etiological investigation can be challenging.
  • MRI and CSF analysis are vital for diagnosis and suggesting etiology.
  • Prompt etiological determination and treatment significantly influence the prognosis of hypertrophic pachymeningitis.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
198
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
247
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
218
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
228
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
162
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
317